PQS: More than 15,000 patients referred as part of NSAID audits
An evaluation of the 2018/19 and 2019/20 non-steroidal anti-inflammatory drugs (NSAID) Pharmacy Quality Scheme (PQS) audits has been published in the British Medical Journal Open Quality.
The evaluation shows that community pharmacy teams spoke to over 165,000 patients during the two audit periods and referred more than 15,000 patients at risk of preventable harm from NSAIDs to prescribers for review.
Commenting on the publication of the audit, Alastair Buxton, Director of NHS Services at PSNC said:
“It is great to see the results of the NSAID audits published. This evaluation helps reinforce the important role that community pharmacy teams play in medicines safety and the benefit of including these types of audits in the Pharmacy Quality Scheme.”
